Jet Lag Disorder
1
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
VP
Vanda PharmaceuticalsWASHINGTON, DC
2 programs1
TasimelteonPhase 21 trial
Transmeridian travel across multiple time zonesN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Vanda PharmaceuticalsTasimelteon
Vanda PharmaceuticalsTransmeridian travel across multiple time zones
Clinical Trials (2)
Total enrollment: 144 patients across 2 trials
A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder
Start: Jul 2016Est. completion: Nov 201725 patients
Phase 2Completed
An Observational Study to Investigate the Effects of Rapid Transmeridian Travel
Start: Sep 2015Est. completion: Oct 2017119 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space